Uterine Neoplasms Clinical Trial
Official title:
ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy of Benign or Malignant Tumors of the Uterus. A Stepped-wedge Cluster Randomized Clinical Trial.
The study assesses the impact on quality of care of implementing the ERAS (Enhanced Recovery After Surgery) protocol for hysterectomy of benign or malignant tumors of the uterus in the network of public hospitals in the Regione Piemonte (North-West Italy). Every hospital is a cluster entering the study treating patients according to its current clinical practice. On the basis of a randomized order, each hospital switches from current clinical practice to the adoption of the ERAS protocol.
ERAS (Enhanced Recovery After Surgery) protocol is a multimodal perioperative care pathways designed to achieve early recovery after surgical procedures by maintaining preoperative organ function and reducing the profound stress response following surgery. Even if efficacy and safety of ERAS protocol in gynaecological surgery is well-established in the literature, its implementation is limited to few selected centres in Piemonte. The aim of the study is to extend the implementation of the ERAS protocol to whole regional network of hospitals. Specific objectives are to estimate its impact on different dimensions of quality of care, including length of stay, complications and patient satisfaction, and to identify possible barriers or facilitating factors. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02374411 -
Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients
|
N/A | |
| Completed |
NCT00377520 -
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
|
Phase 2 | |
| Terminated |
NCT01969396 -
Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology
|
N/A | |
| Terminated |
NCT00669422 -
ChemoFx® PRO - A Post-Market Data Collection Study
|
N/A | |
| Recruiting |
NCT01564264 -
Sentinel Node Biopsy in Endometrial Cancer
|
N/A | |
| Completed |
NCT00231855 -
Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
|
Phase 2 | |
| Completed |
NCT04679675 -
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
|
N/A | |
| Completed |
NCT04351139 -
Impact of the COVID-19 Pandemic in Gynecological Oncology
|
||
| Completed |
NCT05004623 -
Early Feasibility Study of the "Easy Light" Fluorecence Imaging System
|
N/A | |
| Completed |
NCT00112307 -
Magnetic Resonance Imaging Guided Gynecologic Brachytherapy
|
N/A | |
| Completed |
NCT02454036 -
Biobehavioral Intervention in Gynecologic Oncology Patients
|
Phase 2 | |
| Completed |
NCT00188578 -
Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03951415 -
Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer
|
Phase 2 | |
| Completed |
NCT01654458 -
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
|
N/A | |
| Completed |
NCT00190918 -
A Trial for Patients With Gestational Trophoblastic Disease
|
Phase 2 | |
| Completed |
NCT00250783 -
Pre-Clinical Models in Gynecological Tumors A Tissue Repository
|
||
| Completed |
NCT00050440 -
Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma
|
Phase 2 | |
| Recruiting |
NCT03624712 -
Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
|
||
| Completed |
NCT00628901 -
A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)
|
Phase 4 | |
| Completed |
NCT00090389 -
Acupuncture for Women's Health Conditions
|
Phase 1 |